Wayne Markowitz's most recent trade in Edwards Lifesciences Corp was a trade of 26,400 Employee Stock Option (Right to Acquire) done . Disclosure was reported to the exchange on May 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edwards Lifesciences | Wayne T. Markowitz | CVP, JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 26,400 | 26,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences | Wayne T. Markowitz | CVP, JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 5,200 | 5,200 | - | - | Performance Rights | |
| Edwards Lifesciences | Wayne T. Markowitz | CVP, JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 5,200 | 22,762 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences | Wayne T. Markowitz | CVP, JAPAC | Sale of securities on an exchange or to another person at price $ 79.73 per share. | 07 May 2026 | 593 | 21,679 (0%) | 0% | 79.7 | 47,280 | Common Stock |
| Edwards Lifesciences | Wayne T. Markowitz | CVP, JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.20 per share. | 07 May 2026 | 264 | 22,498 (0%) | 0% | 83.2 | 21,965 | Common Stock |
| Edwards Lifesciences | Wayne T. Markowitz | CVP, JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.76 per share. | 07 May 2026 | 226 | 22,272 (0%) | 0% | 82.8 | 18,704 | Common Stock |
| Edwards Lifesciences | Wayne Markowitz | CVP, JAPAC | Sale of securities on an exchange or to another person at price $ 86.01 per share. | 08 Dec 2025 | 583 | 17,562 (0%) | 0% | 86.0 | 50,144 | Common Stock |
| Edwards Lifesciences | Wayne Markowitz | CVP, JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2025 | 6,410 | 18,795 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences | Wayne Markowitz | CVP, JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.57 per share. | 11 Sep 2025 | 650 | 18,145 (0%) | 0% | 77.6 | 50,421 | Common Stock |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 17,100 | 17,100 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 3,350 | 3,350 | - | - | Performance Rights | |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 3,350 | 12,349 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.92 per share. | 07 May 2025 | 300 | 8,999 (0%) | 0% | 74.9 | 22,476 | Common Stock |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Sale of securities on an exchange or to another person at price $ 75.08 per share. | 07 May 2025 | 268 | 9,299 (0%) | 0% | 75.1 | 20,121 | Common Stock |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Sale of securities on an exchange or to another person at price $ 73.27 per share. | 06 Dec 2024 | 583 | 9,493 (0%) | 0% | 73.3 | 42,716 | Common Stock |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.52 per share. | 14 Sep 2024 | 648 | 10,033 (0%) | 0% | 68.5 | 44,401 | Common Stock |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 17,800 | 17,800 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 3,350 | 3,350 | - | - | Performance Rights | |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 3,350 | 10,648 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2023 | 19,256 | 19,256 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2023 | 7,262 | 7,262 (0%) | 0% | 0 | Common Stock |